Long-Term Outcomes in Chronic Lymphocytic Leukemia Treated with Ibrutinib: 10-Year Follow-up of a Phase 2 Study
Andy Itsara(National Institutes of Health), Adrian Wiestner(National Institutes of Health), Inhye E. Ahn(Dana-Farber Cancer Institute), Clare Sun(National Heart Lung and Blood Institute), Hao‐Wei Wang(Fu Jen Catholic University), Constance M. Yuan(National Cancer Institute), Emily Bryer(Pennsylvania Hospital), Susan Soto(National Institutes of Health)
Cited by 10
Related Papers
A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma
|Proceedings of the National Academy of Sciences|2003|1k
The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma
|Cancer Cell|2003|927
IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion
|Genes & Development|2010|744
Landscape of somatic mutations and clonal evolution in mantle cell lymphoma
|Proceedings of the National Academy of Sciences|2013|519
CD4/CD8 T-Cell Selection Affects Chimeric Antigen Receptor (CAR) T-Cell Potency and Toxicity: Updated Results From a Phase I Anti-CD22 CAR T-Cell Trial
|Journal of Clinical Oncology|2020|422